Clinical Trials Directory

Trials / Conditions / Hyponatremia

Hyponatremia

112 registered clinical trials studyying Hyponatremia7 currently recruiting.

StatusTrialSponsorPhase
RecruitingEffect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituita
NCT07273630
University Hospital, Basel, SwitzerlandN/A
RecruitingProtein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis
NCT06821802
University Hospital, Basel, SwitzerlandN/A
RecruitingSystematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia
NCT06020495
Assistance Publique - Hôpitaux de ParisPhase 3
RecruitingAnalysis of the Epidemiology, Clinical Presentation and Therapy as Well as Therapy-associated Risk of Demyelin
NCT06781710
University of Cologne
Not Yet RecruitingSaline Infusion Test in Hyponatremia
NCT06498856
University Hospital, Akershus
UnknownLow-dose Tolvaptan for Inpatient Hyponatraemia.
NCT06171100
King's College Hospital NHS Trust
CompletedEffects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIAD
NCT06277336
University Hospital, Basel, SwitzerlandN/A
CompletedMortality and Neurologic Outcomes in Rapid vs. Slow Hyponatremia Correction
NCT06675591
Hospital Italiano de Buenos Aires
Active Not RecruitingHyponatremia Volume Status Analysis by Point-of-care Ultrasound
NCT06013800
Universidad Veracruzana
UnknownPlasma Sodium and Sodium Administration in the ICU
NCT06037928
University Hospital, Linkoeping
Active Not RecruitingHyponatremia - Complications, Prognosis, Epidemiology in Finnish Tertiary Care
NCT07430787
University of Turku
RecruitingRegulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges
NCT06408077
University of CologneN/A
CompletedComparison of Isotonic Versus Hypotonic Fluids in Neonates for Maintenance Fluid Therapy After Surgery
NCT06484608
Rawalpindi Medical CollegeN/A
UnknownCicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium
NCT02709031
Navitas PharmaPhase 1 / Phase 2
CompletedRetrospective Analysis of ECG Changes and Arrhythmias in Patients With Profound Hyponatremia
NCT07255833
University of Cologne
CompletedDelirium Related to Proton Pump Inhibitors Use
NCT05815550
University Hospital, Caen
TerminatedUrea for Chronic Hyponatremia
NCT04588207
Helbert Rondon Berrios, MD, MSPhase 2
CompletedAnalysis of Factors Determining Increase of Serum Sodium in Hyponatremic Patients
NCT05277584
University of Cologne
RecruitingEffects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia
NCT04447911
University Hospital, Basel, SwitzerlandPhase 4
Active Not RecruitingUrea Therapy for Hyponatremia in Subarachnoid Hemorrhage
NCT04552873
University Hospital, GrenobleN/A
UnknownEfficacy and Safety of Bolus Comparing With Continuous Drip of 3% NaCl in Patients With Severe Symptomatic Hyp
NCT04561531
Department of Medical Services Ministry of Public Health of ThailandN/A
CompletedHYPONATREMIA IN COVID-19 PATIENTS
NCT04493268
Hospital Nacional Profesor Alejandro Posadas
CompletedInfluence of Serum Sodium Levels on Bone Metabolism and Turnover in Hospitalized Patients
NCT04227301
University Hospital, Basel, Switzerland
TerminatedImpact of Hyponatremia on Muscle Strength, Gait and Cognitive Function
NCT04020926
Bürgerspital Solothurn
CompletedChanges in Serum Creatinine Levels Can Help Distinguish Hypovolemic From Euvolemic Hyponatremia
NCT04744987
Hospital San Carlos, Madrid
CompletedHyponatremia Due to Poly Ethylene Glycol (PEG)
NCT03787888
Tazeen Rasheed
TerminatedColloid Osmotic Pressure and Osmolality in Hyponatremia
NCT03703713
University Hospital, Linkoeping
CompletedTargeted Correction of Plasma Sodium Levels in Hospitalized Patients With Hyponatremia
NCT03557957
University Hospital, Basel, SwitzerlandN/A
CompletedHypotonic Hyponatremia: Criteria for the Correct Classification of Its Etiology and of Patient Volume Status
NCT04402190
A.O.U. Città della Salute e della Scienza
CompletedSeizures in Infants Hospitalized in Pediatric Intensive Care Unit for Bronchiolitis
NCT04022486
Hospices Civils de Lyon
CompletedEarly Sodium Intake in Preterm Newborns
NCT04035564
Hospital del Niño "Dr. Federico Gomez Santos"Phase 4
CompletedEffects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study
NCT03202667
University Hospital, Basel, SwitzerlandPhase 2 / Phase 3
CompletedThe Association Between Hyponatremia and Osteoporosis in Patients With Epilepsy.
NCT03371199
Rigshospitalet, DenmarkN/A
CompletedBeer for Endurance Exercise Recovery
NCT03032445
State University of New York - Upstate Medical UniversityN/A
CompletedIntravenous Fluids in Hospitalised Children
NCT02926989
University of OuluPhase 4
TerminatedTolvaptan for Advanced or Refractory Heart Failure
NCT02959411
University of CalgaryPhase 4
UnknownComparison of Ringer Lactate and Isotonic Acetate Solution as Perioperative Maintenance Fluid for Children
NCT02936167
Post Graduate Institute of Medical Education and Research, ChandigarhN/A
CompletedHyponatremia Study (Delayed Hyponatremia After Pituitary Surgery)
NCT03636568
Washington University School of MedicineN/A
WithdrawnProtein Supplementation in Thiazide-induced Hyponatremia
NCT02614807
Ottawa Hospital Research InstituteN/A
UnknownRegional Tolvaptan Registry
NCT02666651
Cardiology Research UBCPhase 4
TerminatedAn Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Participants With Euv
NCT02020278
Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 3
CompletedPost-Operative Water Load Following Transsphenoidal Pituitary Surgery
NCT02727686
St. Joseph's Hospital and Medical Center, PhoenixN/A
UnknownPrevalence of Hyponatremia in Dengue Infected Patients: Relationship With Systemic Inflammation.
NCT06109532
Hospital Nacional Profesor Alejandro Posadas
CompletedAn Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in S
NCT02548845
Otsuka Pharmaceutical Europe Ltd
UnknownFactors Associated With Hyponatremia Induced by High-dose Cyclophosphamide
NCT02399358
Diego Hernan Giunta, MD
CompletedAn Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due
NCT02545101
Otsuka Pharmaceutical Europe Ltd
WithdrawnA Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia
NCT02442674
Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 3
CompletedAn Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in It
NCT02573077
Otsuka Pharmaceutical Europe Ltd
TerminatedStudy of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hyp
NCT02012959
Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 3
TerminatedTolvaptan for Patients With Acute Neurological Injuries
NCT02545114
Polderman, Kees, H., MD, PhDN/A
UnknownSafety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage:
NCT02432157
Thomas Jefferson UniversityPhase 1 / Phase 2
CompletedHyponatremia in the Prevention of Hospitalized Patients Falls
NCT03265691
Mª del Carmen Lobo RodríguezN/A
CompletedFluid Tonicity and Hyponatraemia Post Surgery
NCT03840629
National University Hospital, Singapore
TerminatedPharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients
NCT02215148
University of North Carolina, Chapel Hill
WithdrawnReexamining Hypotonic Intravenous Fluid Use
NCT02667977
Ann & Robert H Lurie Children's Hospital of ChicagoN/A
CompletedInfluence of Triathlon on the Electrolyte Balance
NCT02263586
University Hospital of Cologne
CompletedCharacterization of Neuropsychologic and Physical Performance in Geriatric Patients With Hyponatremia.
NCT02242604
Volker Burst
CompletedRelationship Between Heat Wave and Hyponatremia
NCT02012660
University Hospital, Geneva
CompletedUse of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia
NCT01909336
Instituto Tecnologico y de Estudios Superiores de MontereyPhase 3
CompletedEffects of Oral Salt Supplementation on Physical Performance During a Half-ironman
NCT02103491
Camilo Jose Cela UniversityN/A
CompletedHyponatremia and Hypoalbuminemia is Morbimortality Predictors in Coronary Artery Bypass Graft Surgery
NCT02765061
Ankara University
CompletedBioimpedance Spectroscopy for the Differential Diagnosis of Hyponatremia
NCT01838759
Zonguldak Bulent Ecevit University
CompletedEfficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia
NCT01850940
Beijing Friendship Hospital
UnknownTolvaptan for Hyponatremia in Cirrhotic Patients With Ascites
NCT01716611
Konkuk University Medical CenterPhase 4
UnknownThe Effect of Fluid Restriction in Congestive Heart Failure Complicated With Hyponatremia
NCT01748331
Finn GustafssonN/A
TerminatedHyponatremia and Myometrium Contractility. An Invitro Study
NCT01708811
Karolinska University Hospital
CompletedCharacterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia
NCT01879774
University of CologneN/A
TerminatedTolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia
NCT01890694
NYU Langone HealthPhase 4
TerminatedA Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric
NCT01451411
Cumberland PharmaceuticalsPhase 3
UnknownThe Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia
NCT01509170
Hadassah Medical Organization
CompletedCopeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients
NCT01456533
University Hospital, Basel, Switzerland
WithdrawnFrequency and Origin of Dysnatremias in the Emergency Department
NCT01326429
Insel Gruppe AG, University Hospital Bern
TerminatedTolvaptan for In-hospital Hyponatremia
NCT01386372
Mario Negri Institute for Pharmacological ResearchPhase 2
CompletedV2 Receptor Effects on Fluid Regulation and Performance
NCT02084797
Oakland UniversityN/A
CompletedEffect of Tolvaptan on Cognitive Function in Cirrhosis
NCT01556646
Hunter Holmes Mcguire Veteran Affairs Medical CenterPhase 3
Completed0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Critically Ill Children
NCT01301274
Hospital General de Niños Pedro de ElizaldeN/A
UnknownHyponatraemia and Mortality in Schizophrenic and Bipolar Patients: Protocol for a Bayesian Causal Inference St
NCT04409626
Zealand University Hospital
CompletedHyponatremia in the Elderly: Benefit From a Change in Drug Therapy?
NCT01212211
University Hospital, CaenN/A
CompletedVariation in Natremia Using Two Different Maintenance Intravenous Fluids in Postsurgical Hospitalized Children
NCT01251770
Hospital General de Niños Pedro de ElizaldePhase 3
TerminatedEffects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
NCT01227512
Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 3
CompletedIncidence of Hyponatremia in PEG-SD Compared to PEG-ELS
NCT01299779
Thomas Jefferson UniversityN/A
CompletedPost Operative Hyponatremia in the Renal Transplant Population
NCT01456832
Mayo Clinic
CompletedStudy to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Su
NCT00887627
Cumberland PharmaceuticalsPhase 1
TerminatedSafety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure
NCT00843986
Cumberland PharmaceuticalsPhase 3
CompletedStudy to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Live
NCT00851227
Cumberland PharmaceuticalsPhase 1
CompletedTolvaptan Versus Fluid Restriction in SIADH
NCT04119206
University of Erlangen-Nürnberg Medical School
TerminatedUse of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU Patients
NCT00727090
Northwestern UniversityPhase 4
CompletedEffect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver Trans
NCT00839358
Hospital Clinic of BarcelonaPhase 4
CompletedPico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes
NCT00885430
Queen's UniversityPhase 4
TerminatedA Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional
NCT00728091
SanofiPhase 3
WithdrawnSafety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients
NCT00684164
Columbia UniversityPhase 3
UnknownPostoperative Hyponatremia - Are There Gender Differences?
NCT00636857
Karolinska University HospitalN/A
CompletedHypotonic Versus Isotonic Parenteral (HIP) Fluid Trial
NCT00734214
Hamilton Health Sciences CorporationPhase 3
CompletedSubclassification of the Syndrome of Inappropriate ADH Secretion
NCT01341665
University of Wuerzburg
CompletedHypertonic Saline Solution in Heart Failure
NCT00555685
University of Sao PauloPhase 2
Completed0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Hospitalized Children
NCT00632775
The Hospital for Sick ChildrenPhase 3
CompletedEffects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly
NCT00550459
Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 3
CompletedEstablishment of an Algorithm for a Clinical Classfication of Hypoosmolar Hyponatremia
NCT00541944
University of Wuerzburg
CompletedStudy of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic
NCT00478192
Cumberland PharmaceuticalsPhase 3
CompletedA Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia
NCT00435591
Cumberland PharmaceuticalsPhase 4
CompletedTHE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluati
NCT00578695
CardioKine Inc.Phase 3
CompletedInstitutional Registry of Hyponatremia
NCT01370473
Hospital Italiano de Buenos Aires
CompletedMaintenance Intravenous Fluids in Children
NCT00621348
All India Institute of Medical SciencesPhase 3
CompletedSafety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
NCT00264914
SanofiPhase 3
CompletedEfficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
NCT00264927
SanofiPhase 3
CompletedInternational, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Pa
NCT02449044
Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 3
CompletedAn Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia
NCT00379847
Cumberland PharmaceuticalsPhase 3
Completed"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
NCT00201994
Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 3
CompletedEfficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
NCT00032734
SanofiPhase 2
CompletedWater Load Test Value for Hyponatremia
NCT04256499
European Georges Pompidou Hospital
CompletedStudy of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia
NCT00380575
Cumberland PharmaceuticalsPhase 3
CompletedStudy of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia
NCT00492037
Cumberland PharmaceuticalsPhase 3